153 related articles for article (PubMed ID: 32895190)
1. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].
Chen X; Ye R; Dai D; Wu Y; Yu Y; Cheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1065-1071. PubMed ID: 32895190
[TBL] [Abstract][Full Text] [Related]
2. Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma.
Chen X; Cheng B; Dai D; Wu Y; Feng Z; Tong C; Wang X; Zhao J
Cell Death Discov; 2021 Feb; 7(1):33. PubMed ID: 33597510
[TBL] [Abstract][Full Text] [Related]
3. Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells.
Chen X; Jiang W; Yue C; Zhang W; Tong C; Dai D; Cheng B; Huang C; Lu L
J Cancer; 2017; 8(16):3309-3317. PubMed ID: 29158804
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.
Chen XP; Luo JS; Tian Y; Nie CL; Cui W; Zhang WD
Biomed Res Int; 2015; 2015():241983. PubMed ID: 26839882
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.
Yuan L; Hu J; Luo Y; Liu Q; Li T; Parish CR; Freeman C; Zhu X; Ma W; Hu X; Yu H; Tang S
Mol Vis; 2012; 18():1684-95. PubMed ID: 22773906
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.
Liu M; Zhang Y; Liao Y; Chen Y; Pan Y; Tian H; Zhan Y; Liu D
Cancer Biother Radiopharm; 2015 Aug; 30(6):233-9. PubMed ID: 26132704
[TBL] [Abstract][Full Text] [Related]
7. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
Liao BY; Wang Z; Hu J; Liu WF; Shen ZZ; Zhang X; Yu L; Fan J; Zhou J
Tumour Biol; 2016 Mar; 37(3):2987-98. PubMed ID: 26415733
[TBL] [Abstract][Full Text] [Related]
8. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
Chen B; Chen XP; Wu MS; Cui W; Zhong M
Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
[TBL] [Abstract][Full Text] [Related]
9. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
10. Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.
Jiang W; Wang Z; Li X; Li J; Huang Y; Fan X; Duan Y
Dig Dis Sci; 2012 Jan; 57(1):92-8. PubMed ID: 22038506
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
Liu XY; Tang QS; Chen HC; Jiang XL; Fang H
Int J Biol Sci; 2013; 9(6):564-77. PubMed ID: 23847439
[TBL] [Abstract][Full Text] [Related]
12. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.
Huang GL; Li BK; Zhang MY; Wei RR; Yuan YF; Shi M; Chen XQ; Huang L; Zhang HZ; Liu W; Huang BJ; Li H; Zheng XF; Luo XR; Wang HY
PLoS One; 2012; 7(8):e44061. PubMed ID: 22952874
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.
Hu C; Shen SQ; Cui ZH; Chen ZB; Li W
World J Gastroenterol; 2015 May; 21(19):5884-92. PubMed ID: 26019452
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
[TBL] [Abstract][Full Text] [Related]
16. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
18. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
[TBL] [Abstract][Full Text] [Related]
19. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
